Medicine
Showing 581-600 of 2,408 Results
-
Jessica Ferguson Toll
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.
-
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Priya Fielding-Singh
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioI am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.
My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.
I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University. -
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine, Emeritus
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
Daniel Owen Fishman
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Blood & Marrow TransplantationBioAfter graduating from Vanderbilt Medical School, Dr. Fishman completed the Psychiatry Residency Program at University of Pittsburgh Medical Center, where he served as Chief Resident and was lauded with the program’s sole Teaching Award. Thereafter, Dr. Fishman completed the Consultation-Liaison Psychiatry Fellowship also at the University of Pittsburgh Medical Center. During his training, he also served as Chief Fellow was elected into Alpha Omega Alpha, Honors Medical Society. In the subsequent years, Dr. Fishman practiced as a consultation and liaison psychiatrist, simultaneously serving both academic and community hospitals in the Greater Pittsburgh Area. In his outpatient clinic, he managed and treated patients with complex issues linking the domains of neurology and psychiatry, and specialized in nonepileptic episodes.
Dr. Fishman joined the faculty of Stanford University School of Medicine in 2020 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since his appointment, Dr. Fishman has led medical psychiatry services on the medical/surgical units, intensive care units and in the emergency department at Stanford Hospital to provide psychiatric care for patients with acute diagnoses and provide graduate medical education to psychiatry, internal medicine, palliative care, oncology, and neurology trainees. His work on developing a framework for evidence-based best practice guidelines was recognized with a 2020 DLIN/Fischer finalist award.
Dr. Fishman is the appointed Chief of the Inpatient Proactive Psycho-Oncology Service, a service designed to proactively identify patients with psychopathology or who will require psychiatric intervention during their hospitalization. The service helps prevent development and escalation of psychopathology in the inpatient blood and marrow transplant and other cancer populations. His outpatient work is primarily as a psychiatric oncologist at the Stanford Cancer Center where he provides psychiatric consultation services and collaborates closely with his oncology colleagues to deliver comprehensive cancer care.
His clinical and scholarly interests include the interface of medicine and psychiatry, psycho-oncology, catatonia, neuropsychiatry, collaborative care models, psychotherapy for the medically ill, interdisciplinary and graduate medical education. -
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.
Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.
Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv. -
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
